DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Tardif JC. et al.
Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.
J Am Coll Cardiol 2013;
61: 2048-2055.
We do not assume any responsibility for the contents of the web pages of other providers.